Predict your next investment

Kindbody company logo
HEALTHCARE | Medical Facilities & Services / Specialized Healthcare Services
kindbody.com

See what CB Insights has to offer

Founded Year

2018

Stage

Series C | Alive

Total Raised

$125.98M

Valuation

$0000 

Last Raised

$62M | 4 mos ago

About Kindbody

Kindbody contracts directly with employers, solving for the fragmentation of care that members undergo in their reproductive health journey, offering fertility services supported by full-spectrum gynecology and pre and postpartum services under one roof. As an in-network provider, Kindbody is uniquely positioned to integrate with client's major medical plans and run a fertility benefit seamlessly.

Kindbody Headquarter Location

1140 Broadway 11th Floor

New York, New York, 10001,

United States

855-563-2639

Latest Kindbody News

Kindbody Appoints Dean Morbeck, Ph.D., As First Chief Scientific Officer

Sep 23, 2021

Kindbody Appoints Dean Morbeck, Ph.D., As First Chief Scientific Officer Dr. Morbeck Brings More Than 25 Years of Fertility Experience Improving IVF Success Rates, Patient Experience and Building Research Teams Author: Sep 23, 2021 3:12 PM EDT NEW YORK, Sept. 23, 2021 /PRNewswire/ --  Kindbody , the leading fertility and family-building company seeking to revolutionize the patient experience, today announced the appointment of Dean Morbeck, Ph.D., as the Company's Chief Scientific Officer. Dr. Morbeck, a leading researcher in the area of In Vitro Fertilization (IVF), brings more than 25 years of experience in the field. Dr. Morbeck will apply his scientific expertise and highly specialized areas of research to support Kindbody's full-service family-building service offering as the company continues its rapid expansion. "I am delighted to join Kindbody and look forward to working with this amazing team as we seek to further improve the delivery of care to our patients," said Dr. Morbeck. "Kindbody is fully embracing technology and research as a means to improve outcomes and make IVF more effective, but what stands out to me the most is its all-encompassing emphasis on improving the patient experience, something I am very passionate about. I'm thrilled to be joining such an innovative organization that has the potential to transform the IVF experience for patients." "We are thrilled to add an experienced scientist like Dean to help further our mission of using data-driven research to deliver exceptional care," said Annbeth Eschbach, President of Kindbody. "Dean has a wealth of experience in this field and is passionate about delivering the highest quality care to patients. We have no doubt that under his leadership, Kindbody will continue to provide outstanding results to our patients." Under Dr. Morbeck's leadership, Kindbody will conduct research focused on making IVF more successful, ultimately leading to improved pregnancy rates. By leveraging the latest technology, including new medical devices and artificial intelligence (AI), and placing a heavy emphasis on scientific research, Dr. Morbeck and his team will focus on improving embryo culture quality control and embryo selection, factors that directly impact IVF success rates. This unique research capability further establishes Kindbody as a differentiated provider of the highest quality end-to-end care to patients seeking family building and fertility assistance. Dr. Morbeck most recently served as the Scientific Director for Fertility Associates, New Zealand's leading provider of fertility diagnosis, support, and treatment, as well as an Honorary Lecturer in Obstetrics and Gynaecology at the University of Auckland and as an adjunct Associate Professor in the Department of Obstetrics and Gynecology at Monash University in Melbourne. Prior to his role at Fertility Associates, he was an Associate Professor of Obstetrics and Gynecology and Laboratory Medicine and Pathology at the Mayo Clinic, where he spent 10 years. Prior to that, he spent over 10 years as a laboratory director in private practice. He received his Ph.D. in physiology from North Carolina State University and completed his post-doc fellowship at the Mayo Clinic Graduate School of Biomedical Sciences. He also holds an MBA. Dr. Morbeck's research focuses on in vitro stress during embryo culture, specifically, identifying sources of stress and developing improved methods for detection and prevention of factors that cause stress during preimplantation embryo culture. He has also conducted research to explore the benefits of time-lapse imaging for improving conditions and providing better embryo selection. As an embryologist, academic and scientific consultant, Dr. Morbeck has been actively involved in all aspects of fertility care ranging from the patient experience and clinical procedures to improving the quality of the embryo culture environment and decision-making by embryologists. He is passionate about providing the highest quality care to patients experiencing infertility, and has authored numerous publications on quality control, media composition and laboratory KPIs. Morbeck joins a team of other industry veterans at Kindbody, including Founder and CEO Gina Bartasi, a seasoned entrepreneur with 20+ years' experience in healthtech and the founder of Progyny, President Annbeth Eschbach, previously the Founder and CEO of Exhale Spa, Chief Medical Officer, Dr. Lynn Westphal, previously at Stanford Fertility, and Founding OB/GYN, Dr. Fahimeh Sasan, previously of Mount Sinai Health System in New York. About Kindbody Kindbody provides fertility, gynecology, and family-building services at over 300 locations around the country, including signature retail clinics, mobile clinics, and partner clinics. With a mission to deliver a more welcoming, inclusive experience for all, Kindbody leverages proprietary technology to enable high-touch care and superior outcomes at lower prices. Founded in 2018 by CEO Gina Bartasi, Kindbody has raised a total of $122 million in funding from leading investors including Perceptive Advisors, GV (formerly Google Ventures), RRE Capital, Claritas Health Ventures, Rock Springs Capital, NFP Ventures, and TQ Ventures. Its leadership team includes President, Annbeth Eschbach; Chief Financial Officer, Meredith Whitney; Chief Medical Officer, Dr. Lynn Westphal; Chief Business and Legal Officer; Shilpa Patel; Founding Physician, Dr. Fahimeh Sasan; Chief Scientific Officer, Dean Morbeck; Chief Commercial Officer, Cindy Gentry; and Chief Technology Officer, Richard Forsythe. MEDIA INQUIRIES: Amandalyn Jones 319705@email4pr.com 1-855-KND-BODY View original content to download multimedia: https://www.prnewswire.com/news-releases/kindbody-appoints-dean-morbeck-phd-as-first-chief-scientific-officer-301384291.html SOURCE Kindbody

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kindbody

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kindbody is included in 6 Expert Collections, including Women's Health & Wellness.

W

Women's Health & Wellness

957 items

Startups focused on providing products and services catering to women's health and wellbeing.

M

Mental Health/Wellness Tech

974 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.

D

Digital Health 150 (2019)

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

H

Health Plans & Benefits Management

694 items

Companies developing or offering digital platforms and services, including online insurance marketplaces, data analytics for claims adjustment, benefits administration, and payments systems, that help make private health insurance more affordable, navigable, or transparent.

D

Digital Health 150 (2020)

150 items

The winners of the second annual CB Insights Digital Health 150.

D

Digital Health

11,220 items

Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.

Kindbody Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Kindbody Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.